Neurocrine Biosciences | NBIX - Capitalização De Mercado





Capitalização De Mercado Alterar Data
AbbVie USD 435.86B 8.73B 2026-08
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
ALKERMES USD 7.93B 806M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 209.65B 14.21B 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Cytokinetics USD 9.6B 1.95B 2026-08
Enanta Pharmaceuticals USD 122M 98M 2024-12
Exelixis USD 15.27B 1.73B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pfizer USD 153.17B 14.73B 2026-08
Prothena USD 516M 2M 2026-03
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Repligen USD 7.86B 168M 2026-08
Sarepta Therapeutics USD 1.5B 402M 2026-08
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08